SS

Sudeepta Sinha

Active Director Director DIN 08448540
DIN 08448540 First appointment May 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value •••• Premium profile

About Sudeepta Sinha

Data last updated:

Sudeepta Sinha is a Director at Routes Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Routes Pharmaceuticals Private Limited reported revenue of ₹28.9 Lakh (FY 2025).

DIN 08448540
Primary Designation Director
Industry Chemicals
First Appointment 09 May 2019
Oldest Company Age 7 yrs
Largest company Routes Pharmaceuticals Private Limited · ₹28.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 May 20192019₹28.9 Lakh (FY 2025)Active

Board colleagues of Sudeepta Sinha

NameDINCompanyDesignation
Arti Sharma09826405Routes Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Routes Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sudeepta Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudeepta Sinha

Sudeepta Sinha currently holds 1 directorship: Routes Pharmaceuticals Private Limited (Director, since 09 May 2019, revenue ₹28.9 Lakh (FY 2025)).

Sudeepta Sinha was first appointed on 09 May 2019 as Director at Routes Pharmaceuticals Private Limited.

The current boards of Sudeepta Sinha's companies include Arti Sharma (Routes Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available